Vaccination in Pregnancy.


Journal

Deutsches Arzteblatt international
ISSN: 1866-0452
Titre abrégé: Dtsch Arztebl Int
Pays: Germany
ID NLM: 101475967

Informations de publication

Date de publication:
16 Apr 2021
Historique:
received: 24 06 2020
revised: 24 06 2020
accepted: 02 11 2020
entrez: 11 6 2021
pubmed: 12 6 2021
medline: 17 6 2021
Statut: ppublish

Résumé

Vaccination during pregnancy can protect both the expecting mother and the unborn and newborn child from infectious diseases. This review is based on publications retrieved by a selective literature search on the immunological particularities of infectious diseases affecting pregnant women, unborn children, and neonates, with particular attention to the guidelines of the German Standing Committee on Vaccinations (Ständige Impfkommission, STIKO) and the pertinent guidelines. Vaccination during pregnancy protects the expecting mother from a severe course of a number of different infectious diseases. Vaccination with inactivated vaccines against influenza, tetanus, and pertussis is effective, safe, and well tolerated. Women who are pregnant or of child-bearing age should be immunized against tetanus according to the STIKO recommendations. All pregnant women from the second trimester onward should receive an inactivated quadrivalent influenza vaccine. The immunity acquired after vaccination with an acellular pertussis vaccine is present only for a limited time. In a cohort study involving 72,781 pregnant women, pertussis vaccination during pregnancy was found to yield 91% protection against pertussis for their subsequently born children in the first three months of life. Further types of vaccine can also be given during pregnancy if indicated. Additional reasonable measures to protect the health of mother and child include the vaccination of other persons in close contact as well as the closure of relevant vaccination gaps among young adults, particularly women of child-bearing age. Treating physicians play a crucial role in encouraging vaccine acceptance by their patients. Maternal immunization is a safe and effective strategy for giving neo - nates passive immune protection against life-threatening infections by the vertical transmission of maternal antibodies until they are able to build up their own adaptive immunity.

Sections du résumé

BACKGROUND BACKGROUND
Vaccination during pregnancy can protect both the expecting mother and the unborn and newborn child from infectious diseases.
METHODS METHODS
This review is based on publications retrieved by a selective literature search on the immunological particularities of infectious diseases affecting pregnant women, unborn children, and neonates, with particular attention to the guidelines of the German Standing Committee on Vaccinations (Ständige Impfkommission, STIKO) and the pertinent guidelines.
RESULTS RESULTS
Vaccination during pregnancy protects the expecting mother from a severe course of a number of different infectious diseases. Vaccination with inactivated vaccines against influenza, tetanus, and pertussis is effective, safe, and well tolerated. Women who are pregnant or of child-bearing age should be immunized against tetanus according to the STIKO recommendations. All pregnant women from the second trimester onward should receive an inactivated quadrivalent influenza vaccine. The immunity acquired after vaccination with an acellular pertussis vaccine is present only for a limited time. In a cohort study involving 72,781 pregnant women, pertussis vaccination during pregnancy was found to yield 91% protection against pertussis for their subsequently born children in the first three months of life. Further types of vaccine can also be given during pregnancy if indicated. Additional reasonable measures to protect the health of mother and child include the vaccination of other persons in close contact as well as the closure of relevant vaccination gaps among young adults, particularly women of child-bearing age. Treating physicians play a crucial role in encouraging vaccine acceptance by their patients.
CONCLUSION CONCLUSIONS
Maternal immunization is a safe and effective strategy for giving neo - nates passive immune protection against life-threatening infections by the vertical transmission of maternal antibodies until they are able to build up their own adaptive immunity.

Identifiants

pubmed: 34114547
pii: arztebl.m2021.0020
doi: 10.3238/arztebl.m2021.0020
pmc: PMC8287076
doi:
pii:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

262-268

Références

Vaccine. 2018 Oct 8;36(42):6354-6360
pubmed: 30219367
Nat Immunol. 2017 Jun;18(6):622-632
pubmed: 28459433
Gastroenterology. 2012 Apr;142(4):773-781.e2
pubmed: 22198276
Am J Obstet Gynecol. 2011 Apr;204(4):334.e1-5
pubmed: 21272845
Int J Epidemiol. 2010 Apr;39 Suppl 1:i102-9
pubmed: 20348112
BMC Health Serv Res. 2019 Sep 2;19(1):616
pubmed: 31477095
Vaccine. 2018 Aug 28;36(36):5379-5384
pubmed: 28822646
Hum Vaccin. 2009 May;5(5):315-21
pubmed: 19011374
Clin Infect Dis. 2016 Dec 1;63(suppl 4):S236-S243
pubmed: 27838678
N Engl J Med. 2017 Mar 30;376(13):1256-1267
pubmed: 28355514
Clin Dev Immunol. 2012;2012:985646
pubmed: 22235228
PLoS Med. 2011 May;8(5):e1000441
pubmed: 21655318
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12048-53
pubmed: 23818581
J Infect Dis. 2004 Jul 15;190(2):335-40
pubmed: 15216470
Vaccine. 2014 Jul 16;32(33):4131-9
pubmed: 24928791
N Engl J Med. 2014 Sep 4;371(10):918-31
pubmed: 25184864
Clin Infect Dis. 2017 Nov 29;65(12):1977-1983
pubmed: 29028938
Influenza Other Respir Viruses. 2013 Nov;7(6):1033-9
pubmed: 23170853
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Aug;61(8):945-951
pubmed: 29943259
J Perinatol. 2010 Feb;30(2):93-7
pubmed: 19812588
Clin Perinatol. 2015 Mar;42(1):77-103, viii
pubmed: 25677998
Reprod Sci. 2014 Dec;21(12):1434-51
pubmed: 24899469
Ann Med. 2018 May;50(3):193-208
pubmed: 29308916
J Matern Fetal Neonatal Med. 2012 Sep;25(9):1800-9
pubmed: 22339083
Nat Rev Immunol. 2017 Aug;17(8):469-482
pubmed: 28627518
N Engl J Med. 2014 Jun 5;370(23):2211-8
pubmed: 24897084
Obstet Gynecol. 2015 Nov;126(5):1069-1074
pubmed: 26444109
Nat Rev Drug Discov. 2020 Apr;19(4):239-252
pubmed: 32060419
Vaccine. 2020 Jan 29;38(5):963-978
pubmed: 31839467
Vaccine. 2014 Dec 12;32(52):7057-64
pubmed: 25285883
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004790
pubmed: 16625613
J Hepatol. 2008 Feb;48(2):335-52
pubmed: 18096267
Emerg Infect Dis. 2008 Jan;14(1):95-100
pubmed: 18258087
Obstet Gynecol. 2019 Apr;133(4):739-753
pubmed: 30913173
Med Trop (Mars). 2010 Aug;70(4):321-4
pubmed: 22368925
Pediatrics. 2016 Jun;137(6):
pubmed: 27244843
Am J Epidemiol. 1998 Dec 1;148(11):1094-102
pubmed: 9850132
Matern Child Health J. 2013 Sep;17(7):1325-31
pubmed: 23001819

Auteurs

Marianne Röbl-Mathieu (M)

Gynecologist's office, Munich; Member of STIKOGynecologist's office, MunichDepartment of Pediatrics, University Hospital WürzburgInstitute of Virology, Ulm University Hospital, Ulm; Member of STIKOWorking Group Vaccination in Pregnancy, German Professional Association of Gynecologists, Munich.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH